| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.70B | +8.3% |
| Cost of Revenue | $2.05B | +9.2% |
| R&D Expense | $7.5M | -1.8% |
| SG&A Expense | $318.7M | +13.9% |
| Operating Income | $380.6M | -0.6% |
| Interest Expense | $2.0M | -95.6% |
| Pre-tax Income | $348.7M | +8.5% |
| Income Tax | $66.4M | -11.5% |
| Net Income | $281.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.1M | -2.2% |
| Accounts Receivable | $99.1M | +41.2% |
| Inventory | $40.3M | +47.1% |
| Current Assets | $930.0M | +13.7% |
| Total Assets | $2.87B | +4.5% |
| Current Liabilities | $474.2M | +26.4% |
| Long-term Debt | $1.04B | -13.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $408.4M | +12.3% |
| Capital Expenditures | $153.6M | +1.6% |
| Investing Cash Flow | -$154.6M | +0.7% |
| Financing Cash Flow | -$252.8M | -49.2% |
| Free Cash Flow | $254.8M | +19.9% |
| +14.7% |
| EPS (Basic) | $3.08 | +14.9% |
| EPS (Diluted) | $3.07 | +14.6% |
| Stockholders' Equity |
| $1.08B |
| +15.8% |